Surfactant treatment of neonatal acute respiratory distress syndrome: is "fortification" the answer?
Chima
Ranjit S
RS
Zingarelli
Basilia
B
D006801:Humans; D007231:Infant, Newborn; D047908:Intracellular Signaling Peptides and Proteins / Q000627:therapeutic use*; D016328:NF-kappa B / Q000037:antagonists & inhibitors*; D012127:Respiratory Distress Syndrome, Newborn / Q000188:drug therapy*; D013501:Surface-Active Agents / Q000627:therapeutic use*
D047908:Intracellular Signaling Peptides and Proteins; D016328:NF-kappa B; D013501:Surface-Active Agents; C015482:protein kinase modulator